Search Results - "Lefkowitz MP"

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT‐HF): Baseline characteristics compared to recent randomized controlled heart failure trials.

Authors: Bavendiek, Udo Thomas, Nele Henrike Berliner, Dominik et al.

Source: European Journal of Heart Failure. Jul2025, Vol. 27 Issue 7, p1224-1233. 10p.

Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model.

Authors: Burger, Pascal M. Savarese, Gianluigi Tromp, Jasper et al.

Source: European Journal of Heart Failure. Nov2023, Vol. 25 Issue 11, p1962-1975. 14p.

Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.

Authors: Kapelios, Chris J. Laroche, Cécile Crespo‐Leiro, Maria G. et al.

Source: European Journal of Heart Failure. Aug2020, Vol. 22 Issue 8, p1424-1437. 14p. 1 Diagram, 4 Charts, 2 Graphs.

Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world

Authors: Kapelios, Chris J. Lainscak, Mitja Savarese, Gianluigi et al.

Source: European Journal of Heart Failure. Nov2019, Vol. 21 Issue 11, p1383-1397. 15p. 4 Charts, 3 Graphs.

Early administration of renin–angiotensin system inhibitors improves survival and cardiac remodeling in heart failure with preserved ejection fraction.

Authors: Kono, Yuka Sonoda, Kunihiro Ohtake, Kazuo et al.

Source: PLoS ONE. 3/12/2026, Vol. 21 Issue 3, p1-16. 16p.

Dapagliflozin mitigates myocardial inflammation and metabolic stress in heart failure through STAT1 inhibition: Evidence from multi-omics analyses and experimental exploration.

Authors: He, Lianqi Zhang, Di Zhang, Shiwen et al.

Source: PLoS ONE. 2/27/2026, Vol. 21 Issue 2, p1-23. 23p.

This result is not displayed to guests.
Login for full access.

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial.

Authors: Chimura, Misato Yang, Mingming Henderson, Alasdair D. et al.

Source: European Journal of Heart Failure. Nov2025, Vol. 27 Issue 11, p2301-2312. 12p.

Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.

Authors: Kondo T Jhund PS Anand IS et al.

Source: JACC. Heart failure [JACC Heart Fail] 2025 Jun; Vol. 13 (6), pp. 927-939. Date of Electronic Publication: 2025 Mar 12.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.

Authors: Wachter, Rolf Senni, Michele Belohlavek, Jan et al.

Source: European Journal of Heart Failure. Aug2019, Vol. 21 Issue 8, p998-1007. 10p. 2 Diagrams, 2 Charts, 2 Graphs.

Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction.

Authors: Bergo, Kaja Knudsen Nordén, Einar Sjaastad Bendiksen, Bård Andre et al.

Source: PLoS ONE. 10/24/2025, Vol. 20 Issue 10, p1-14. 14p.

Efficacy and safety of sacubitril-valsartan in Maintenance Hemodialysis patients with hypertension:A retrospective study.

Authors: Jiang, Lili Ran, Jing Zhu, Yu et al.

Source: PLoS ONE. 9/4/2025, Vol. 20 Issue 9, p1-11. 11p.

Longitudinal blood pressure and cardiovascular outcomes in heart failure: An individual patient data pooling analysis of clinical trials.

Authors: Li, Jing‐Wei Wang, Jiang Chen, Yunlong et al.

Source: European Journal of Heart Failure. Sep2025, Vol. 27 Issue 9, p1686-1694. 9p.

Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.

Authors: Saldarriaga, Clara I. Zannad, Faiez McMullan, Ciaran J. et al.

Source: European Journal of Heart Failure. Aug2025, Vol. 27 Issue 8, p1426-1435. 10p.

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Authors: Pandey, Ambarish Kolkailah, Ahmed A. McGuire, Darren K. et al.

Source: European Journal of Heart Failure. Mar2025, Vol. 27 Issue 3, p521-526. 6p.

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review.

Authors: Luo, Yuxiang Xiao, Wenbin Sener, Yusuf Z. et al.

Source: European Journal of Heart Failure. Dec2025, Vol. 27 Issue 12, p2747-2759. 13p.

Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial–mesenchymal transition in chronic hepatic injury.

Authors: Zhu, Bingwen Dai, Xiyu Liu, Chunyan et al.

Source: Journal of Translational Medicine. 11/13/2025, Vol. 23 Issue 1, p1-22. 22p.

Primary cardioprotective effect of sacubitril/valsartan in breast cancer patients receiving adjuvant therapy.

Authors: Hsu, Yu‐Ling Lee, Chun‐Hui Chung, Wei‐Pang et al.

Source: European Journal of Heart Failure. Nov2025, Vol. 27 Issue 11, p2141-2151. 11p.

Clinical and financial implications of inpatient and outpatient management of worsening heart failure.

Authors: Greene, Stephen J. Kaltenbach, Lisa A. Fonarow, Gregg C. et al.

Source: European Journal of Heart Failure. Nov2025, Vol. 27 Issue 11, p2019-2030. 12p.

Contemporary guideline‐directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE‐HF study.

Authors: Malgie, Jishnu Wilde, Mariëlle I. Clephas, Pascal R.D. et al.

Source: European Journal of Heart Failure. Jul2024, Vol. 26 Issue 7, p1549-1560. 12p.